AiVita Biomedical Gets $2M

Irvine-based AiVita Biomedical, a biopharmaceuticals company focused on regenerative medicine, has raised $2M in a Series A financing. The funding came from California Technology Ventures. As part of the funding, Alex Suh of CTV will join the company's board of directors. AiVita Biomedical is led by Dr. Hans Keirstead, and is focused on stem cell-based skin care product which helps address several signs of aging, and a novel cancer immunotherapy applicable to multiple solid tumor types. The company said the funding goes towards general operations and the further development of its pipeline.